WallStSmart
SAVA

Cassava Sciences Inc

NASDAQ: SAVA · HEALTHCARE · BIOTECHNOLOGY

$1.45
+0.69% today

Updated 2026-04-30

Market cap
$142.03M
P/E ratio
P/S ratio
2.54x
EPS (TTM)
$-2.22
Dividend yield
52W range
$1 – $5
Volume
0.5M

Cassava Sciences Inc (SAVA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-11.83M$2.23M$11.16M$-14.69M$-143000.00$-260000.00$-7.17M$-6.95M$-9.55M$-9.05M$-12.23M$-8.24M$-4.77M$-2.51M$-5.38M$-30.20M$-77.51M$-82.03M$-116.93M$-32.25M
Capital expenditures$94000.00$696000.00$2.12M$0.00$0.00$463000.00$0.00$0.00$80000.00$195000.00$75000.00$18000.00$18000.00$18000.00$346000.00$22.21M$2.71M$414000.00$103000.00$581000.00
Depreciation
Stock-based comp$6.47M$6.29M$10.21M$6.66M$20.13M$5.43M$6.61M$3.10M$3.76M$3.46M$4.33M$2.97M$2.39M$1.30M$988000.00$1.76M$2.07M$4.59M$16.29M$19.58M
Free cash flow$-11.92M$1.53M$9.04M$-14.69M$-143000.00$-723000.00$-7.17M$-6.95M$-9.63M$-9.25M$-12.31M$-8.26M$-4.79M$-2.53M$-5.73M$-52.41M$-80.23M$-82.44M$-117.03M$-32.83M
Investing cash flow
Financing cash flow
Dividends paid$85.69M
Share repurchases
Debt repayment
Net change in cash$68.35M$-23.79M$-767000.00$-8.00M$-9.29M$-14.68M$-6.14M$9.33M$3.27M$70.42M$139.93M